AIV
74
2
VRSK
82
2
SIG
50
-5
MOS
43
-5
AMG
57
2
ED
55
3
RIG
55
-6
SYK
68
4
C
62
-3
FTI
84
2
CF
56
3
LYB
41
-2
MMM
42
5
KSS
26
-15
ADM
36
5
CTSH
60
3
WAT
64
7
CMCSA
48
-2
SWKS
51
-2
FFIV
69
2
AIV
74
2
VRSK
82
2
SIG
50
-5
MOS
43
-5
AMG
57
2
ED
55
3
RIG
55
-6
SYK
68
4
C
62
-3
FTI
84
2
CF
56
3
LYB
41
-2
MMM
42
5
KSS
26
-15
ADM
36
5
CTSH
60
3
WAT
64
7
CMCSA
48
-2
SWKS
51
-2
FFIV
69
2
Financhill
Back

Biomarin Pharmaceutical Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
64

BMRN
Biomarin Pharmaceutical

Last Price:
65.20
Seasonality Move:
8.34%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
135.80
Seasonality Move:
14.88%
Buy
64
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $64.88. The Score for BMRN is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $64.88
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.61 Sell
Relative Strength Index (14 RSI): 42.45 Sell
Chaikin Money Flow: 545123 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.72 - 68.58) Sell
Bollinger Bands (100): (67.47 - 87.01) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 63.45 Buy
20-day SMA: 65.18 Sell
50-day SMA: 68.06 Sell
200-day SMA: 80.82 Sell
8-day EMA: 64.32 Buy
20-day EMA: 65.46 Sell
50-day EMA: 69.38 Sell
200-day EMA: 79.1 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.23 per share, and an increase next year of $0.83 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):